Mesenchymal stem cells protect against sepsis-associated acute kidney injury by inducing Gal-9/Tim-3 to remodel immune homeostasis

References

• Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.
   PubMedGoogle Scholar
• Zilberman-Itskovich S, Efrati S. Mesenchymal stromal cell uses for acute kidney injury-current available data and future perspectives: a mini-review. Front Immunol. 2020;11:1369.
   PubMed Web of Science ®Google Scholar
• Luo CJ, Zhang FJ, Zhang L, et al. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock. 2014;41(2):123–129.
   PubMed Web of Science ®Google Scholar
• Wang WH, Lin CY, Chang MR, et al. The role of galectins in virus infection – A systemic literature review. J Microbiol Immunol Infect. 2020;53(6):925–935.
   PubMedGoogle Scholar
• Wu C, Thalhamer T, Franca RF, et al. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity. 2014;41(2):270–282.
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson AC, Schubart A, et al. The tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6(12):1245–1252.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Morishita A, Niki T, et al. Galectin-9 prolongs the survival of septic mice by expanding tim-3-expressing natural killer T cells and PDCA-1+ CD11c + macrophages. Crit Care. 2013;17(6):R284.
   PubMed Web of Science ®Google Scholar
• Németh K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42–49.
   PubMed Web of Science ®Google Scholar
• Chao YH, Wu HP, Wu KH, et al. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLOS One. 2014;9(10):e110338.
   PubMed Web of Science ®Google Scholar
• Fazekas B, Griffin MD. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade. Kidney Int. 2020;97(6):1130–1140.
   PubMed Web of Science ®Google Scholar
• Han X, Yang Q, Lin L, et al. Interleukin-17 enhances immunosuppression by mesenchymal stem cells. Cell Death Differ. 2014;21(11):1758–1768.
   PubMed Web of Science ®Google Scholar
• Prevosto C, Zancolli M, Canevali P, et al. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell–lymphocyte interaction. Haematologica. 2007;92(7):881–888.
   PubMed Web of Science ®Google Scholar
• Sioud M, Mobergslien A, Boudabous A, et al. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. Int J Oncol. 2011;38(2):385–390.
   PubMed Web of Science ®Google Scholar
• Karimi Z, Janfeshan S, Kargar Abarghouei E, et al. Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats. Bioimpacts. 2020;11(3):219–226.
   PubMed Web of Science ®Google Scholar
• Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol. 2009;20(8):1744–1753.
   PubMed Web of Science ®Google Scholar
• Lee H, Nho D, Chung HS, et al. CD4+ CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int. 2010;78(11):1100–1109.
   PubMed Web of Science ®Google Scholar
• Kamali AN, Noorbakhsh SM, Hamedifar H, et al. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol. 2019;105:107–115.
   PubMed Web of Science ®Google Scholar
• Flierl MA, Rittirsch D, Gao H, et al. Adverse functions of IL-17A in experimental sepsis. FASEB J. 2008;22(7):2198–2205.
   PubMed Web of Science ®Google Scholar
• Brunialti MK, Santos MC, Rigato O, et al. Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis. PLoS One. 2012;7(5):e37393.
   PubMed Web of Science ®Google Scholar
• Wang L, Li Q, Wang L, et al. The role of Th17/IL-17 in the pathogenesis of primary nephrotic syndrome in children. Kidney Blood Press Res. 2013;37(4-5):332–345.
   PubMed Web of Science ®Google Scholar
• Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFN-γ- mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010;120(1):331–342.
   PubMed Web of Science ®Google Scholar
• Gautron AS, Dominguez-Villar M, de Marcken M, et al. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44(9):2703–2711.
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol. 2011;350:1–15.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Shan NN. The role of T cell immunoglobulin and mucin domain-3 in immune T hrombocytopenia. Scand J Immunol. 2014;79(4):231–236.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shu Q, Gao L, et al. Increased tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol. 2010;137(2):288–295.
   PubMed Web of Science ®Google Scholar
• Yang X, Jiang X, Chen G, et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol. 2013;190(5):2068–2079.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao S, Huang S, et al. Upregulated tim-3/galectin-9 expressions in acute lung injury in a murine malarial model. Parasitol Res. 2016;115(2):587–595.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Luan H, Wang L, et al. Galectin-9 ameliorates anti-GBM glomerulonephritis by shifting the balance of activated CD4+ T cell immune response in mice. Am J Physiol Renal Physiol. 2014;306:822–832.
   Web of Science ®Google Scholar
• Luo C, Luo F, Zhang L, et al. Knockout of interleukin-17A protects against sepsis-associated acute kidney injury. Ann Intensive Care. 2016;6(1):56.
   PubMedGoogle Scholar
• Hu J, Zhang L, Wang N, et al. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int. 2013;84(3):521–531.
   PubMed Web of Science ®Google Scholar
• Congjuan L, Feng L, Lin C, et al. Stem Cells Protect Against Sepsis-associated Acute Kidney Injury by Inducing Gal-9/Tim-3 to Remodel Immune Homeostasis. Res Square. DOI:10.21203/rs.3.rs-734898/v2
   Google Scholar